biOasis Appoints New Chief Financial Officer and Corporate Secretary VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jun 20, 2014) - biOasis...
biOasis Enters Investor Relations Agreement with Gale Capital Corporation VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jun 16, 2014) - biOasis...
biOasis Secures DTC Eligibility VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 8, 2014) - biOasis Technologies Inc. (OTCQX:BIOAF...
biOasis Delivers siRNA to the Brain Using its Transcend Peptide Vector The Ability to Deliver siRNAs to the Brain Represents a Major Advance in...
biOasis Discovers the Keys to Transcend to Advance Its Program for the Delivery of Therapeutics Across the Blood-Brain Barrier This Represents A...
biOasis Presents Results From It's BT2111 Program at International Cancer Research Conference biOasis and collaborators from Alexandria...
biOasis Receives Patent Allowances for Lysosomal Storage Disease Therapeutic in Europe and Canada Key Patent Allowances Represent Major Step...
biOasis Enters Into a License Agreement With Medimmune for Second Generation Versions of biOasis's Transcend This Represents A Positive Step...
Thu, Mar 06, 2014 12:00 - biOasis Technologies Inc. (BIOAF: OTCQX International) - Piggyback Qualified - Effective Thu, Mar 06, 2014, BIOAF is...
biOasis to Begin Trading on OTCQX® Marketplace in the U.S. VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 24, 2014) - biOasis...
biOasis Technologies Begins Trading on OTCQX® PR Newswire NEW YORK, Feb. 24, 2014 NEW YORK, Feb. 24, 2014 /PRNewswire/ -- OTC Markets Group Inc...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.